Transcendent Capital Group LLC Merck & Co., Inc. Transaction History
Transcendent Capital Group LLC
- $195 Billion
- Q3 2024
A detailed history of Transcendent Capital Group LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Transcendent Capital Group LLC holds 1,599 shares of MRK stock, worth $158,892. This represents 0.09% of its overall portfolio holdings.
Number of Shares
1,599
Previous 13,887
88.49%
Holding current value
$158,892
Previous $1.72 Billion
89.44%
% of portfolio
0.09%
Previous 0.99%
Shares
4 transactions
Others Institutions Holding MRK
# of Institutions
3,827Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.8 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.8 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.53 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.88 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $252B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...